Update on Pharmaceutical Intervention for Disorders of Consciousness and Agitation After Traumatic Brain Injury in Children
Authors:
- Stacy J. SuskauerSSStacy J. Suskauer
- Melissa K. TrovatoMTMelissa K. Trovato
Abstract
Responsiveness and agitation are common targets for pharmaceutical intervention after traumatic brain injury (TBI) in children. This focused review presents a critical discussion of the limited literature available on the use of medications for disorders of consciousness and agitation in children with TBI. For disorders of consciousness, evidence from several small studies supports a potential benefit of dopaminergic agents for improving responsiveness in some children with lower levels of function after TBI. Larger studies, likely requiring multicenter collaborations, are needed to more definitively address questions regarding the use of medications for responsiveness in children with TBI. The literature regarding use of pharmaceutical agents for agitation in children with TBI is even more limited. The dearth of literature regarding the effects of medications used for agitation in children with TBI highlights the need for additional basic and clinical science contributions in this area.Keywords
This publication has 20 references indexed in Scilit:
- Placebo-Controlled Trial of Amantadine for Severe Traumatic Brain InjuryNew England Journal of Medicine, 2012
- Neuropharmacology in Pediatric Brain Injury: A ReviewPM&R, 2010
- Zolpidem for Persistent Vegetative State - A Placebo-Controlled Trial in PediatricsNeuropediatrics, 2010
- Pharmacokinetics of Amantadine in Children With Impaired Consciousness due to Acquired Brain Injury: Preliminary Findings Using a Sparse‐sampling TechniquePM&R, 2010
- Effects of Amantadine in Children with Impaired Consciousness Caused by Acquired Brain InjuryAmerican Journal of Physical Medicine & Rehabilitation, 2009
- Behavior management for children and adolescents with acquired brain injuryDevelopmental Disabilities Research Reviews, 2009
- Assessing the relationship between the WNSSP and therapeutic participation in adolescents in low response states following severe traumatic brain injuryBrain Injury, 2009
- Dopamine Agonist Therapy in Low-Response Children Following Traumatic Brain InjuryJournal of Child Neurology, 2006
- Amantadine in Pediatric Patients with Traumatic Brain InjuryAmerican Journal of Physical Medicine & Rehabilitation, 2004
- The use of dopamine enhancing medications with children in low response states following brain injuryBrain Injury, 2003